Egypts Multiple Sclerosis treatment market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Multiple sclerosis is a type of autoimmune, chronic, inflammatory disease which affects the central nervous system, specifically the brain and other tissues of the body. The treatment focuses on a fast recovery, slowing the progression of the disease, and reduces the symptoms of multiple sclerosis. Types of symptoms include vision loss, pain, fatigue, and impaired coordination. This duration of disease, symptoms, and severity vary from person to person

In Egypt, the predestined prevalence of MS is deemed to be 9.01 cases per 100 000 population. This figure was considerably high among female patients aged more than 17 years, accounting for 27.5 cases per 100 000 population. Overall, it affects over 1,20,000 people in Egypt. Even with the inclusion of MS in the insurance coverage plan of the Ministry of Health, the number of treated patients under insurance represents around 6% of the total pool thus MS represents a huge financial burden on uninsured patients and their families who can barely afford direct medical costs.



Market Drivers

Multiple Sclerosis treatment demand has increased as compared to the precise year with an increasing prevalence of multiple sclerosis along with the increasing need for better multiple sclerosis treatment options and rising government initiatives.

The disease affects women more often than men. According to the National Multiple Sclerosis Society, women may be up to three times more likely than men to get MS. 50% of Egypts population comprises females. Thus, the risk of rising prevalence of the disease will boost the MS market in the forecast period.

High cost of treatment and panels is expected to restraint the demand for multiple sclerosis treatment and expected to slow down the growth of the multiple sclerosis treatment market in the forecasted period.